Delfi Diagnostics
PrivateLast Round
VC Round
Dec 18, 2025
Total Funding Raised
$330.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Delfi Diagnostics is a biotechnology company that develops high-performance, accessible blood-based tests for the early detection of cancer using machine learning to analyze cell-free DNA fragmentation patterns.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delfi Diagnostics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Delfi Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 18, 2025 | ||||
| Corporate Funding | Jun 4, 2024 | ||||
| Series B | Jul 18, 2022 | ||||
| Series A | Jan 12, 2021 | ||||
| Seed | Aug 1, 2019 |
Delfi Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Series B |
| Brown Advisory | Series B |
| Bollinger Investment Group | Series A |
| TD Securities | Series B, Series A |
| Blue Owl Capital | Series B, Series A |
| Osage University Partners | Series B |
| OrbiMed | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Five poster presentations at AACR 2026 Annual Meeting.
- Apr 6, 2026
Showcasing advances to whole-genome cfDNA platform at AACR 2026.
Delfi Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Delfi Diagnostics's valuation, stock price, and market status.